One of the core strengths of a Clinical Research Organization is its R & D activity, which in its current circumstances needs huge investments to keep pace with the highly competitive global market. Added to that is the growing complexities of conducting clinical studies and increasingly stringent regulations, that needs to be complied with.

In the current scenario, CROs are gaining momentum as major players within the healthcare spectrum, buoyed by financial and risk mitigation pressures as well as regulatory scrutiny. As pharmaceutical and biotechnology companies continue to outsource drug discovery, CROs will continue to grow at a rapid pace, wherein an enterprise quality management system like eQM would be adequately required to manage all critical quality and compliance processes with a single and a centralized system. With low investment and high value addition, eQM perfectly fits the CRO space.